UK markets open in 1 hour 17 minutes

Asensus Surgical, Inc. (2TX.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.2942-0.0038 (-1.28%)
At close: 04:07PM CEST
Full screen
Previous close0.2980
Bid0.2946 x N/A
Ask0.3100 x N/A
Day's range0.2902 - 0.2942
52-week range0.1830 - 0.5250
Avg. volume6,377
Market cap84.573M
Beta (5Y monthly)1.29
PE ratio (TTM)N/A
EPS (TTM)-0.2800
Earnings date08 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.00
  • GlobeNewswire

    Asensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZ

    KARL STORZ to acquire Asensus for $0.35 per share in cash Creating a leading surgical robotics division within KARL STORZ RESEARCH TRIANGLE PARK, N.C., June 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) (“Asensus Surgical” or “Asensus”), a global leader of innovative digital solutions for the operating room, today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with KARL STORZ Endoscopy-America, Inc. ("KARL STORZ"), a wholly o


    Asensus Surgical Inc (ASXC) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial ...

    Despite a slight revenue increase and strategic partnerships, Asensus Surgical faces ongoing financial hurdles and potential acquisition uncertainties.

  • GlobeNewswire

    Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024

    RESEARCH TRIANGLE PARK, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced its operating and financial results for the first quarter 2024. Recent Highlights Announced non-binding acquisition proposal and exclusivity arrangement with KARL STORZ SE & Co. KG (KARL STORZ)KARL STORZ to provide up to $20 million in financingNearly 900 procedures performed globally during the quarterOne S